These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18387410)

  • 1. Intravenous immunoglobulins and mucous membrane pemphigoid.
    Mignogna MD; Leuci S; Piscopo R; Bonovolontà G
    Ophthalmology; 2008 Apr; 115(4):752-752.e1. PubMed ID: 18387410
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
    Galdos M; Etxebarría J
    Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
    Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S
    J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y; Amin KG; Mohan K; Ahmed AR
    Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide.
    Musette P; Pascal F; Hoang-Xuan T; Heller M; Lok C; Deboise A; Dubertret L; Prost C
    Arch Dermatol; 2001 Jan; 137(1):101-2. PubMed ID: 11176680
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid.
    Witte M; Zillikens D; Shimanovich I
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e321-e324. PubMed ID: 29443427
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment in laryngeal pemphigoid.
    Gürcan HM; Ahmed AR
    Clin Exp Dermatol; 2009 Dec; 34(8):884-6. PubMed ID: 19094130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
    Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Bernard P;
    Ann Dermatol Venereol; 2011 Mar; 138(3):259-63. PubMed ID: 21397156
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid.
    Hegarty AM; Ormond M; Sweeney M; Hodgson T
    Eur J Dermatol; 2010; 20(2):223-4. PubMed ID: 20123643
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulin as clinical immune-modulating therapy.
    Gilardin L; Bayry J; Kaveri SV
    CMAJ; 2015 Mar; 187(4):257-264. PubMed ID: 25667260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitamin A therapy of pemphigoid of the conjunctiva].
    Tseng CG; Maumenee H; Maumenee AE
    Fortschr Ophthalmol; 1986; 83(6):637-40. PubMed ID: 3546036
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucous membrane pemphigoid with severe esophageal stricture.
    Barbosa Ldo N; Silva RS; Verardino GC; Gripp AC; Alves Mde F
    An Bras Dermatol; 2011; 86(3):565-8. PubMed ID: 21738978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid.
    Wertheim MS; Males JJ; Cook SD; Tole DM
    Br J Ophthalmol; 2006 Apr; 90(4):516. PubMed ID: 16547343
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of cicatrical pemphigoid with DDS].
    Mashkilleĭson AL; Golousenko IIu; Antonova TN
    Vestn Dermatol Venerol; 1984 Oct; (10):37-9. PubMed ID: 6393631
    [No Abstract]   [Full Text] [Related]  

  • 18. Cicatricial pemphigoid treated with intravenous immunoglobulin.
    Urcelay ML; McQueen A; Douglas WS
    Br J Dermatol; 1997 Sep; 137(3):477-8. PubMed ID: 9349361
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in mucous membrane pemphigoid.
    Daniel E; Thorne JE
    Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
    Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
    Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.